The Role of Altered Glutathione Status in the Development of Parkinson’s Disease

Introduction: The Antioxidant Glutathione

Glutathione Levels and Oxidative Stress in Parkinson’s Disease

Relevance of GSH Deficit to Other Nigral Changes in Parkinson’s Disease

Putative Mechanism(s) Eliciting the Alterations in the Glutathione Pathway in Parkinson’s Disease

Consequences of Nigral GSH Deficit in Parkinson’s Disease

Site of Occurrence of GSH Depletion: Is Parkinson’s Disease a Neuronal or a Glial Disorder?

GSH, a Potential Candidate for Neuroprotective Treatment in Parkinson’s Disease?

Conclusions

References